Emcure Pharmaceuticals Limited, a prominent name in the Indian pharmaceutical industry, is set to launch its IPO, aiming to raise ₹1,952.03 crores. This comprehensive guide provides all the critical details, key dates, and financial insights about the Emcure Pharma IPO.
Key Details of Emcure Pharma IPO
The Emcure Pharma IPO consists of a fresh issue and an offer for sale. Here is a detailed overview:
| IPO Component | Details |
|---|---|
| Total Issue Size | ₹1,952.03 crores |
| Fresh Issue | 0.79 crore shares aggregating to ₹800.00 crores |
| Offer for Sale | 1.14 crore shares aggregating to ₹1,152.03 crores |
This table highlights the breakdown of the total issue size, indicating both the fresh issue and the offer for sale components.
Important Dates for Emcure Pharma IPO
The timeline for the Emcure Pharma IPO is crucial for investors. Below are the key dates to remember:
| Event | Date |
|---|---|
| IPO Opening Date | July 3, 2024 |
| IPO Closing Date | July 5, 2024 |
| Basis of Allotment Finalization | July 8, 2024 |
| Initiation of Refunds | July 9, 2024 |
| Credit of Shares to Demat | July 9, 2024 |
| Listing Date | July 10, 2024 |
This table summarizes the tentative schedule for the IPO, ensuring investors are aware of all important deadlines.
Price Band and Lot Size Of Emcure Pharma IPO
The Emcure Pharma IPO has set a price band and lot size that investors need to consider:
| Price Band | ₹960 to ₹1008 per share |
|---|---|
| Minimum Lot Size | 14 Shares |
| Minimum Investment (Retail) | ₹14,112 |
| Minimum Investment (sNII) | ₹211,680 (15 lots, 210 shares) |
| Minimum Investment (bNII) | ₹1,001,952 (71 lots, 994 shares) |
This table provides the price band and investment requirements for different investor categories.
Emcure Pharma IPO Reservation Details
The IPO has specific reservation categories, ensuring fair distribution among different types of investors:
| Investor Category | Shares Offered |
|---|---|
| QIB | Not more than 50% of the Net Issue |
| Retail | Not less than 35% of the Net Issue |
| NII (HNI) | Not more than 15% of the Net Issue |
This table explains the reservation details, giving clarity on the allocation for various investor categories.
Financial Performance and Key Metrics Of Emcure Pharma IPO
The financial data of Emcure Pharmaceuticals Limited showcases the company’s performance over the years:
| Financial Metrics | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|
| Assets | ₹7,806.16 Cr | ₹6,672.53 Cr | ₹6,063.47 Cr |
| Revenue | ₹6,715.24 Cr | ₹6,031.72 Cr | ₹5,918.86 Cr |
| Profit After Tax | ₹527.58 Cr | ₹561.85 Cr | ₹702.56 Cr |
| Net Worth | ₹2,952.28 Cr | ₹2,501.13 Cr | ₹1,987.55 Cr |
| Reserves & Surplus | ₹2,722.40 Cr | ₹2,293.77 Cr | ₹1,791.03 Cr |
| Total Borrowing | ₹2,091.94 Cr | ₹2,202.42 Cr | ₹2,102.19 Cr |
This table presents the financial performance, showcasing key metrics such as assets, revenue, profit, and more.
Key Performance Indicators Of Emcure Pharma IPO
Emcure Pharma’s key performance indicators (KPIs) provide insight into the company’s efficiency and profitability:
| KPI | Value |
|---|---|
| Market Capitalization | ₹19,029.89 Cr |
| ROE | 16.90% |
| ROCE | 19.37% |
| Debt/Equity | 0.67 |
| RoNW | 16.87% |
| P/BV | 6.18 |
This table highlights critical KPIs, reflecting the company’s market standing and financial health.
Objectives of the Emcure Pharma IPO
The funds raised through the IPO will be utilized for:
- Repayment and/or prepayment of certain outstanding borrowings.
- General corporate purposes.
Promoter Holding and Company Overview Of Emcure Pharma IPO
Emcure Pharmaceuticals Limited, incorporated in 1981, is a leading Indian pharmaceutical company. Here’s an overview of promoter holdings and company details:
| Promoter | Holding Pre Issue | Holding Post Issue |
|---|---|---|
| Satish Mehta | 98.90% | – |
| Sunil Mehta | 98.90% | – |
This table provides information about the company promoters and their shareholding percentages.
Contact and Registrar Details Of Emcure Pharma IPO
For any inquiries or issues, investors can contact Emcure Pharmaceuticals Limited or their IPO registrar:
| Emcure Pharmaceuticals Limited | Registrar |
|---|---|
| Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Pune – 411 057 | Link Intime India Private Ltd |
| Phone: +91 20 3507 0033 | Phone: +91-22-4918 6270 |
| Email: investors@emcure.co.in | Email: emcure.ipo@linkintime.co.in |
| Website: Emcure Pharmaceuticals | Website: Link Intime |
This table provides the contact details of Emcure Pharmaceuticals and their IPO registrar for investor assistance.
Conclusion
Emcure Pharmaceuticals Limited’s IPO is a significant opportunity for investors, offering a well-established company with a robust financial background. With a clear understanding of the IPO details, investment requirements, and financial performance, investors can make informed decisions.
For those looking to delve deeper into the specifics, the Emcure Pharma IPO RHP provides comprehensive information. To create a demat account and start investing, visit GRM Bulls for seamless financial services and trading learning.
Stay updated and make informed investment decisions with GRM Bulls!
